However, no association existed between PRL-3 and other clinicopathological parameters such as age (pooled OR = 0.88; 95% CI = 0.55–1.38; P = 0.566, random effect), sex (pooled OR = 1.18; 95% CI = 0.86–1.62; P = 0.306, fixed effect), tumor size (pooled OR = 1.61; 95% CI = 0.76–3.42; P = 0.217, random effect), and tumor differentiation (pooled OR = 1.12; 95% CI = 0.81–1.55; P = 0.496, fixed effect). The gene discussed is PTP4A3; the disease is neoplasm.